Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Simulations Plus, Inc.

SLP ✓ COMPLIANT ☆ Track — members

NASDAQ · Healthcare · Advanced Medical Equipment & Technology ·

USA Small Cap Analyst: HOLD

Last Close

$18.42

▲ +0.00%

Market Cap $372.54M · Vol 41.37K

Key Metrics

P/E Ratio

46.02

FWD: 38.78

Market Cap

$372.54M

Small Cap

Div Yield

0.00%

Quarterly dividend

EPS Growth

+113.66%

YoY

RSI (14)

57.14

Momentum

Beta

1.31

vs Market

52W High

$21.01

12.33% below

52W Low

$11.11

65.80% above

Volume

41.37K

Avg 54.33K

P/B

2.29

Price-to-book

ROE

N/A

Return on equity

Free Float

83.09%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Simulations Plus, Inc. (SLP) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does SLP pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.00%

+0.60%

+11.70%

+47.71%

YTD

+1.04%

+28.27%

-55.02%

-58.92%

Financials & Valuation

TTM · Annual

Total Revenue	$79.18M
Net Income	$-64,718,000.00
Revenue Growth (YoY)	+7.48%
Gross Margin	58.38%
Operating Margin	8.20%
Net Profit Margin	-81.74%
ROE	N/A
ROA · ROIC	-42.23% · N/A

P/E Ratio	46.02
Forward P/E (FY1)	38.78
PEG Ratio	N/A
P/S	3.60
P/B	2.29
P/FCF	19.78
EPS Growth	+113.66%
Outstanding Shares	20.22M

Technical Indicators

50-Day SMA	$18.34
200-Day SMA	$16.38
RSI (14)	57.14
Beta	1.31
52-Week High	$21.01
52-Week Low	$11.11

Volume Today	41.37K
Avg Daily Volume (30D)	54.33K
Relative Volume	0.76x
Volatility (10D)	1.15
Volatility (30D)	2.31
Free Float	83.09%

Analyst Consensus

HOLD

Current Price $18.42

Mean Target $17.25

52W Low$11.11 52W High$21.01

Current

Target

$11.11 $21.01

Current Analyst target

-6.35% downside risk · 5 analysts

Identifiers

ExchangeNASDAQ

FIGIBBG001S9TQV4

ISINUS8292141053

CountryUSA

Sub-IndustryMedical Software & Technology Services

Earnings DateNov 30, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

VEEV Veeva Systems Inc. +0.54% PME.AX Pro Medicus Limited -1.51% SECT B.ST Sectra AB -0.28% HTFL Heartflow, Inc. +9.65% OMCL Omnicell Inc +1.67%

Company Profile

Simulations Plus, Inc. specializes in model-informed and artificial intelligence (AI)-accelerated drug development. The Company helps its clients by accelerating the discovery, development, and commercialization of pharmaceuticals and other products through science-based software and consulting solutions. The Company’s segments include Software and Services. The Company's Software segment supports pharmaceutical research, development, and commercialization through simulation, modeling, and AI-driven prediction. Its main products include GastroPlus, ADMET Predictor, MonolixSuite, and others for disease modeling and training, as well as Pro-ficiency for clinical operations. Its Services segment includes advanced consulting services across the entire drug development lifecycle. Its scientists and engineers specialize in drug discovery, pharmacokinetics, pharmacodynamics, drug modeling, clinical trial data analysis, regulatory strategy, and medical communications.